- Home
- SOLV vs PCVX Comparison
SOLV vs PCVX Comparison
Compare SOLV & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOLV
- PCVX
- Stock Information
- Founded
- SOLV 2023
- PCVX 2013
- Country
- SOLV United States
- PCVX United States
- Employees
- SOLV N/A
- PCVX N/A
- Industry
- SOLV
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- SOLV
- PCVX Health Care
- Exchange
- SOLV NYSE
- PCVX Nasdaq
- Market Cap
- SOLV 12.7B
- PCVX 4.4B
- IPO Year
- SOLV N/A
- PCVX 2020
- Fundamental
- Price
- SOLV $78.50
- PCVX $33.25
- Analyst Decision
- SOLV Hold
- PCVX Strong Buy
- Analyst Count
- SOLV 11
- PCVX 10
- Target Price
- SOLV $80.29
- PCVX $136.50
- AVG Volume (30 Days)
- SOLV 808.6K
- PCVX 1.5M
- Earning Date
- SOLV 08-07-2025
- PCVX 08-05-2025
- Dividend Yield
- SOLV N/A
- PCVX N/A
- EPS Growth
- SOLV N/A
- PCVX N/A
- EPS
- SOLV 2.18
- PCVX N/A
- Revenue
- SOLV $8,308,000,000.00
- PCVX N/A
- Revenue This Year
- SOLV $4.11
- PCVX N/A
- Revenue Next Year
- SOLV $0.14
- PCVX N/A
- P/E Ratio
- SOLV $36.07
- PCVX N/A
- Revenue Growth
- SOLV 1.29
- PCVX N/A
- 52 Week Low
- SOLV $47.16
- PCVX $27.66
- 52 Week High
- SOLV $85.92
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- SOLV N/A
- PCVX 45.61
- Support Level
- SOLV N/A
- PCVX $32.00
- Resistance Level
- SOLV N/A
- PCVX $34.63
- Average True Range (ATR)
- SOLV 0.00
- PCVX 1.33
- MACD
- SOLV 0.00
- PCVX -0.06
- Stochastic Oscillator
- SOLV 0.00
- PCVX 33.67
About SOLV SOLVENTUM CORP
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.